Insider · CIK 0001013702

KING RICHARD

Reports to the SEC for 4 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001013702

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-30	SPRBSPRUCE BIOSCIENCES, INC.J Other	Director, Chief Executive Officer	JOther	+2,230 sh	$9.53	+$21.2K	2,230
2021-01-28	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+155K sh	—	—	155,000
2018-06-21	Adamas Pharmaceuticals IncS Sale	Chief Operating Officer	SSale	−2,501 sh	$25.48	−$63.7K	48,856
2018-03-06	Adamas Pharmaceuticals IncA Award	Chief Operating Officer	AAward	+11K sh	—	—	50,661
2018-03-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+66K sh	—	—	66,000
2018-02-28	Adamas Pharmaceuticals IncA Award	Chief Operating Officer	AAward	+10K sh	$25.07	+$251K	39,661
2017-05-05	Adamas Pharmaceuticals IncA Award	Chief Operating Officer	AAward	+28.1K sh	—	—	28,125
2017-05-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+169K sh	—	—	168,750
2014-03-02	TLPHTALPHERA, INC.F Tax Payment	Director	FTax Payment	−11.6K sh	$11.43	−$133K	134,567
2014-02-04	TLPHTALPHERA, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+175K sh	—	—	175,000
2013-02-05	TLPHTALPHERA, INC. · Common Stock (Right to Buy)A Award	Director	AAward	−507K sh	—	—	507,057
2012-02-13	TLPHTALPHERA, INC. · Common Stock (Right to Buy)A Award	Director	AAward	−262K sh	—	—	262,214
2011-06-09	TLPHTALPHERA, INC.P Purchase	Director	PPurchase	+3,500 sh	$4.56	+$16K	126,957
2011-03-02	TLPHTALPHERA, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,208
2011-03-02	TLPHTALPHERA, INC.A Award	Director	AAward	+123K sh	—	—	123,457
2006-01-03	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+5,000 sh	$19.50	+$97.5K	8,788
2006-01-03	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−5,000 sh	—	—	71,000
2006-01-03	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−5,000 sh	$50.38	−$252K	3,788
2005-12-01	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$66.39	−$199K	3,776
2005-12-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−3,000 sh	—	—	76,000
2005-12-01	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+3,000 sh	$19.50	+$58.5K	6,776
2005-10-03	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−3,000 sh	—	—	12,000
2005-10-03	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+3,000 sh	$22.55	+$67.7K	6,743
2005-10-03	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$66.79	−$200K	3,743
2005-09-01	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+3,000 sh	$22.55	+$67.7K	6,743
2005-09-01	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$67.80	−$203K	3,743
2005-09-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−3,000 sh	—	—	15,000
2005-08-01	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$71.34	−$214K	3,734
2005-08-01	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+3,000 sh	$22.55	+$67.7K	6,734
2005-08-01	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$71.34	−$214K	3,734
2005-08-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−3,000 sh	—	—	18,000
2005-07-01	KOS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	+3,000 sh	$22.55	+$67.7K	6,230
2005-07-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP, Commercial Operations	MExercise/Conversion	−3,000 sh	—	—	21,000
2005-07-01	KOS PHARMACEUTICALS INCS Sale	EVP, Commercial Operations	SSale	−3,000 sh	$65.29	−$196K	3,230
2005-02-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP, Commercial Operations	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 64
KING RICHARD0001209191-21-045418
SEC(opens sec.gov)
Jan 294
KING RICHARD0001209191-21-006375
SEC(opens sec.gov)
Jun 224
KING RICHARD0001209191-18-039249
SEC(opens sec.gov)
Mar 94
KING RICHARD0001209191-18-018671
SEC(opens sec.gov)
Mar 14
KING RICHARD0001209191-18-014826
SEC(opens sec.gov)
May 54
Adamas Pharmaceuticals Inc0001209191-17-030401
SEC(opens sec.gov)
Mar 114
ACELRX PHARMACEUTICALS INC0001181431-14-012064
SEC(opens sec.gov)
Feb 64
ACELRX PHARMACEUTICALS INC0001181431-14-005576
SEC(opens sec.gov)
Feb 74
KING RICHARD0001181431-13-007807
SEC(opens sec.gov)
Feb 134
KING RICHARD0001181431-12-008332
SEC(opens sec.gov)
Jun 134
KING RICHARD0001181431-11-036389
SEC(opens sec.gov)
Mar 44
KING RICHARD0001181431-11-015787
SEC(opens sec.gov)
Jan 44
KING RICHARD0001018952-06-000001
SEC(opens sec.gov)
Dec 54
KING RICHARD0001018952-05-000092
SEC(opens sec.gov)

Companies

Address

C/O ACELRX PHARMACEUTICALS, INC. 575 CHESAPEAKE DRIVE

REDWOOD CITY, CA, 94063